Show Search Form
human indexable | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||
registered interest | |||||||||||||||
answer date | |||||||||||||||
date | |||||||||||||||
date tabled | |||||||||||||||
ddp created | |||||||||||||||
answering body |
|
||||||||||||||
question status | Tabled | ||||||||||||||
answering dept id | 17 | ||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||
ddp modified |
|
||||||||||||||
hansard heading | Voluntary Scheme for Branded Medicines Pricing and Access | ||||||||||||||
house id | 1 | ||||||||||||||
identifier | 257056 | ||||||||||||||
legislature |
|
||||||||||||||
parliament number | 57 | ||||||||||||||
question first answered |
|
||||||||||||||
question text | To ask the Secretary of State for Health and Social Care, whether the review of the methods for the NICE Technology Appraisal Programme referred to in the 2019 voluntary scheme for branded medicines pricing and access will include support for earlier patient access to innovative medicines. | ||||||||||||||
session |
|
||||||||||||||
session number | 1 | ||||||||||||||
tabling member constituency | Bolton West | ||||||||||||||
tabling member printed |
|
||||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 257056 | ||||||||||||||
type |
|
||||||||||||||
uin | 257056 | ||||||||||||||
version | 1 | ||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||
answer |
|
||||||||||||||
creator |
|
||||||||||||||
publisher | 25259 | ||||||||||||||
tabling member |
|